A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells

Investigational New Drugs

Saved in:

Bibliographic Details
Main Authors:	Ma, B., Goh, B.C., Tan, E.H., Lam, K.C., Soo, R., Leong, S.S., Wang, L.Z., Mo, F., Chan, A.T.C., Zee, B., Mok, T.
Other Authors:	PHARMACY
Format:	Article
Published:	2014
Subjects:	3-AP Gemcitabine Methemoglobinemia Non-small-cell lung cancer Triapine
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/105569
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-105569
record_format	dspace
spelling	sg-nus-scholar.10635-1055692023-11-01T07:48:37Z A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells Ma, B. Goh, B.C. Tan, E.H. Lam, K.C. Soo, R. Leong, S.S. Wang, L.Z. Mo, F. Chan, A.T.C. Zee, B. Mok, T. PHARMACY 3-AP Gemcitabine Methemoglobinemia Non-small-cell lung cancer Triapine Investigational New Drugs 26 2 169-173 INNDD 2014-10-29T01:47:25Z 2014-10-29T01:47:25Z 2008-04 Article Ma, B., Goh, B.C., Tan, E.H., Lam, K.C., Soo, R., Leong, S.S., Wang, L.Z., Mo, F., Chan, A.T.C., Zee, B., Mok, T. (2008-04). A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells. Investigational New Drugs 26 (2) : 169-173. ScholarBank@NUS Repository. 01676997 http://scholarbank.nus.edu.sg/handle/10635/105569 000253765400007 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	3-AP Gemcitabine Methemoglobinemia Non-small-cell lung cancer Triapine
spellingShingle	3-AP Gemcitabine Methemoglobinemia Non-small-cell lung cancer Triapine Ma, B. Goh, B.C. Tan, E.H. Lam, K.C. Soo, R. Leong, S.S. Wang, L.Z. Mo, F. Chan, A.T.C. Zee, B. Mok, T. A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
description	Investigational New Drugs
author2	PHARMACY
author_facet	PHARMACY Ma, B. Goh, B.C. Tan, E.H. Lam, K.C. Soo, R. Leong, S.S. Wang, L.Z. Mo, F. Chan, A.T.C. Zee, B. Mok, T.
format	Article
author	Ma, B. Goh, B.C. Tan, E.H. Lam, K.C. Soo, R. Leong, S.S. Wang, L.Z. Mo, F. Chan, A.T.C. Zee, B. Mok, T.
author_sort	Ma, B.
title	A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
title_short	A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
title_full	A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
title_fullStr	A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
title_full_unstemmed	A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
title_sort	multicenter phase ii trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-ap, triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/105569
_version_	1781788068934582272

A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells

Similar Items